2m 2m 2m 2m 2m 2m 2m
KALARIS THERAP (KLRS)
NASDAQ
$3.72+$0.21 (+5.98%)
Price as of Aug 03, 2026 10:21 AM EDT- $83.5MMarket Cap
- 30.48%1-Year Change
- BiotechnologyIndustry
KALARIS THERAP (KLRS)
$3.72+$0.21 (+5.98%)
KLRS | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $3.51 | ||
Change | +$0.03 (+0.86%) | ||
Open | $3.43 | ||
High | $3.61 | ||
Low | $3.40 | ||
Previous Close | $3.48 | ||
Volume | 71,946 | ||
30-Day Average Volume | 599,610 | ||
1-Week Change | -5.90% | ||
1-Month Change | -13.76% | ||
1-Year Change | 30.48% | ||
3-Year Change | N/A | ||
5-Year Change | N/A | ||
Fundamentals | |||
Shares Outstanding | 23.8M | ||
Total Assets | $109.8M | ||
Market Cap | $83.5M | ||
Enterprise Value | $49.1M | ||
Period: QTR TTM FY | |||
Revenue | N/A | ||
Net Income | -$10.9M | ||
Free Cash Flow | -$11.6M | ||
EBIT | -$10.9M | ||
EBITDA | -$10.8M | ||
Net Working Capital | $90.4M | ||
EPS | -$0.46 | ||
Enterprise Value/EBITDA | -5 | ||
Enterprise Value/Revenue | N/A | ||
P/B | 1 | ||
P/E | -8 | ||
PEG | -1 | ||
Price/Free Cash Flow | -7 | ||
Price/Operating Cash Flow | -7 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue